1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Enteral and Parenteral Medical Nutrition Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Enteral and Parenteral Medical Nutrition Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Enteral and Parenteral Medical Nutrition Market Regional Analysis
6.2 North America Enteral and Parenteral Medical Nutrition Market Revenue 2021-2028 (US$ Million)
6.3 North America Enteral and Parenteral Medical Nutrition Market Forecast Analysis
7. North America Enteral and Parenteral Medical Nutrition Market Analysis – by Indication
7.1 Elderly
- 7.1.1 Overview
- 7.1.2 Elderly: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.2 Gastrointestinal Disorders
- 7.2.1 Overview
- 7.2.2 Gastrointestinal Disorders: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.3 Diabetes
- 7.3.1 Overview
- 7.3.2 Diabetes: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.4 Cancer
- 7.4.1 Overview
- 7.4.2 Cancer: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.5 Respiratory Disorders
- 7.5.1 Overview
- 7.5.2 Respiratory Disorders: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.6 Alzheimer's Disease
- 7.6.1 Overview
- 7.6.2 Alzheimer's Disease: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.7 Dementia
- 7.7.1 Overview
- 7.7.2 Dementia: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.8 Renal Disease
- 7.8.1 Overview
- 7.8.2 Renal Disease: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.9 Liver Failure
- 7.9.1 Overview
- 7.9.2 Liver Failure: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.10 Post COVID-19
- 7.10.1 Overview
- 7.10.2 Post COVID-19: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.11 Other Indications
- 7.11.1 Overview
- 7.11.2 Other Indications: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
8. North America Enteral and Parenteral Medical Nutrition Market Analysis – by Nutrition Type
8.1 Supplemental
- 8.1.1 Overview
- 8.1.2 Supplemental: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.2 Sole Source
- 8.2.1 Overview
- 8.2.2 Sole Source: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
9. North America Enteral and Parenteral Medical Nutrition Market Analysis – by Form
9.1 Liquid
- 9.1.1 Overview
- 9.1.2 Liquid: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.2 Powder
- 9.2.1 Overview
- 9.2.2 Powder: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.3 Semi Solid
- 9.3.1 Overview
- 9.3.2 Semi Solid: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
10. North America Enteral and Parenteral Medical Nutrition Market Analysis – by Product Type
10.1 General
- 10.1.1 Overview
- 10.1.2 General: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
10.2 Disease Specific
- 10.2.1 Overview
- 10.2.2 Disease Specific: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast, 2021-2028 (US$ Million)
11. North America Enteral and Parenteral Medical Nutrition Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Key
Country, 2024 and 2028 (%)
- 11.2.1.1 North America Enteral and Parenteral Medical Nutrition Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 US: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
- 11.2.1.1.2 US: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
- 11.2.1.1.3 US: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
- 11.2.1.1.4 US: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Product Type
- 11.2.1.2 Canada:
North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Canada: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
- 11.2.1.2.2 Canada: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
- 11.2.1.2.3 Canada: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
- 11.2.1.2.4 Canada: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Product Type
- 11.2.1.3 Mexico :
North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Mexico : North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
- 11.2.1.3.2 Mexico : North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
- 11.2.1.3.3 Mexico : North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
- 11.2.1.3.4 Mexico : North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Product Type
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott Laboratories
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 B. Braun SE
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Baxter International Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Fresenius Kabi AG
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Medica Nutrition Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Medtrition Inc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Nestle SA
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Nutricia International BV
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Nutrisens SAS
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations